| Identification | Back Directory | [Name]
(S)-1-((S)-2-Hydroxy-2-(4-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)piperidine-3-carboxylic acid | [CAS]
1265321-86-5 | [Synonyms]
BMS960
BMS-960
BMS 960
(S)-1-((S)-2-Hydroxy-2-(4-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)piperidine-3-carboxylic acid | [Molecular Formula]
C26H23F3N4O5 | [MDL Number]
MFCD31555857 | [MOL File]
1265321-86-5.mol | [Molecular Weight]
528.48 |
| Hazard Information | Back Directory | [Description]
BMS-960 is a SlP agonist. Sphingosine-1 -phosphate (SlP) has been demonstrated to induce many cellular effects, including those that result in platelet aggregation, cell proliferation, cell morphology, tumor cell invasion, endothelial cell and leukocyte chemotaxis, endothelial cell in vitro angiogenesis, and lymphocyte trafficking. SlP receptors are therefore good targets for a wide variety of therapeutic applications such as tumor growth inhibition, vascular disease, and autoimmune diseases. |
|
| Company Name: |
Alichem Inc.
|
| Tel: |
800-467-2918 |
| Website: |
www.alichem.com |
|